Bioelectric medicines, also known as Electroceuticals, are medical devices that are used to restore health in patients. Bioelectric medicines function through neurostimulation and modulation of the nervous systems through electrical impulses. Global Bioelectric Medicine Market will reach $39.06 billion by 2030, growing by a revised CAGR of 7.3% over 2020-2030 driven by growing geriatric population and rising acceptance of bioelectric medicines.
Highlighted with 106 table...
Bioelectric medicines, also known as Electroceuticals, are medical devices that are used to restore health in patients. Bioelectric medicines function through neurostimulation and modulation of the nervous systems through electrical impulses. North America Bioelectric Medicine Market is projected to grow by 7.0% annually in the forecast period and reach $15.82 billion by 2030 owing to the growing geriatric population and rising acceptance of bioelectric medicines.
Highli...
Bioelectric medicines, also known as electroceuticals, are medical devices that are used to restore health in patients. Bioelectric medicines function through neurostimulation and modulation of the nervous systems through electrical impulses. Europe Bioelectric Medicine Market was valued at $5,859.6 million in 2020 and will grow by 6.4% annually over 2020-2030 owing to the growing geriatric population and rising acceptance of bioelectric medicines.
Highlighted with 70 tables and 43...
Bioelectric medicines, also known as electroceuticals, are medical devices that are used to restore health in patients. Bioelectric medicines function through neurostimulation and modulation of the nervous systems through electrical impulses. Asia Pacific Bioelectric Medicine Market will grow by 9.3% annually with a total addressable market cap of $60.93 billion over 2021-2030 owing to the growing geriatric population and rising acceptance of bioelectric medicines.
Highl...
Global Disinfection Robots Market will reach $4,828.7 million by 2030, growing by 29.5% annually over 2020-2030 considering the impact of COVID-19 pandemic. The unit shipment of disinfection robots is anticipated to grow by 27.3% annually over the forecast years. The market is driven by the high incidence of hospital-acquired infections, increasing investments on healthcare infrastructure, and growing adoption of advanced medical robots across a variety of verticals. Highlighted with 85 t...
North America disinfection robots market is expected to grow by 28.0% annually in the forecast period and reach $1,538.4 million by 2030, driven by the high incidence of hospital acquired infections, increasing investments on healthcare infrastructure, and growing adoption of advanced medical robots across a variety of verticals. Highlighted with 25 tables and 56 figures, this 102-page report “North America Disinfection Robots Market 2020-2030 by Product Type (UV, HPV, Spray, Combined),...
Europe disinfection robots market was valued at $112.4 million in 2020 and will grow by 27.4% annually over 2020-2030 owing to the high incidence of hospital acquired infections, increasing investments on healthcare infrastructure, and growing adoption of advanced medical robots across a variety of verticals. Highlighted with 35 tables and 60 figures, this 110-page report “Europe Disinfection Robots Market 2020-2030 by Product Type (UV, HPV, Spray, Combined), Technology (Semi-Autonomous...
Asia Pacific disinfection robots market will grow by 33.0% annually with a total addressable market cap of $5,624.2 million over 2021-2030 owing to the high incidence of hospital acquired infections, increasing investments on healthcare infrastructure, and growing adoption of advanced medical robots across a variety of verticals. Highlighted with 32 tables and 59 figures, this 109-page report “Asia Pacific Disinfection Robots Market 2020-2030 by Product Type (UV, HPV, Spray, Combined), ...
Global monoclonal antibodies market will reach $329.6 billion by 2030, growing by 10.9% annually over 2020-2030, driven by the increasing incidences of new cancer cases and other diseases, growth in geriatric population, increasing pharmaceutical R&D spending, upsurge in healthcare expenditure, and the rising adoption of cost-efficient biosimilar monoclonal antibodies. Highlighted with 83 tables and 84 figures, this 165-page report “Global Monoclonal Antibodies (mAbs) Market 2020-2030 b...
North America monoclonal antibodies market is projected to grow by 10.4% annually in the forecast period and reach $133.4 billion by 2030, driven by the increasing incidences of new cancer cases and other diseases, growth in geriatric population, increasing pharmaceutical R&D spending, upsurge in healthcare expenditure, and the rising adoption of cost-efficient biosimilar monoclonal antibodies. Highlighted with 24 tables and 48 figures, this 102-page report “North America Monoclonal Ant...
